Categories: DiagnosticsNews

Driving Force Acquires Vertebral Motion Analysis (VMA®) Technology from Wenzel Spine

CHICAGO–(BUSINESS WIRE)–Driving Force today announced the acquisition of the groundbreaking Vertebral Motion Analysis (VMA®) technology from Wenzel Spine, marking a pivotal step in the advancement of spinal imaging and diagnostics. The acquisition positions Driving Force VMA as the sole owner and operator of the most advanced, FDA-cleared motion imaging system for diagnosing spinal ligament injuries with unmatched precision.


Developed with input from leading spine surgeons and backed by peer-reviewed studies in The Spine Journal, the VMA® system uses dynamic fluoroscopy and proprietary software to deliver objective, quantifiable, accurate, consistent, and reliable (med-legal) evidence of spinal instability injuries often missed by standard MRI and X-ray. This capability is transforming care for patients suffering from chronic spinal pain, personal injury cases, workers’ compensation claims, and sports-related injuries.

“Acquiring the VMA® technology allows us to take control of its future, accelerate innovation, and expand access to providers and patients nationwide,” said Walter Bergeron and Sam Frentzas, Founders of Driving Force. “We believe the VMA® will become the gold standard for diagnosing spinal ligament injuries, giving providers a competitive edge, improving patient outcomes, and increasing case value in the legal and insurance arenas.”

Driving Force plans to build a national network of imaging centers and strategic provider partnerships, offering exclusive regional rights to medical groups who adopt the technology. The acquisition also ensures continued development of the VMA® platform, training, and backend reporting infrastructure, maintaining the rigorous standards set by its surgical and radiological origins.

“The transition from Wenzel Spine to Driving Force is an exciting new chapter,” said William Wilson, CEO of Wenzel Spine, “We’re confident the technology will reach its full potential under Driving Force’s vision and leadership.”

The acquisition solidifies Driving Force’s mission: to make motion-based spinal imaging as indispensable as MRI in injury diagnostics, redefining how the medical and legal communities evaluate and treat spinal injuries.

Financial terms of the VMA® asset sale were not disclosed.

About Driving Force VMA, LLC

Driving Force is the exclusive owner and distributor of Vertebral Motion Analysis (VMA®) technology, the only FDA-cleared spinal motion imaging platform designed to deliver quantifiable evidence of spinal instability. The company partners with physicians, imaging centers, and legal professionals to bring advanced diagnostic capabilities to markets nationwide.

To learn more, visit: www.drivingforcecompany.com

About Wenzel Spine, Inc.

Headquartered in Austin, Texas, Wenzel Spine, Inc. is a privately held medical technology company committed to advancing the standard of care for spinal disorders through minimally invasive surgical innovation and data-driven analytics. Wenzel Spine’s technologies are used by leading spine and pain physicians across the country to streamline surgical procedures and improve patient outcomes.

To learn more, visit: www.wenzelspine.com

Contacts

Media contact information:
Walter Bergeron

vip@drivingforcecompany.com

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

19 hours ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

24 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

1 day ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

1 day ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

1 day ago